FFAR2 and malignant colon neoplasm: Further experimental studies confirmed that intestinal barrier function-related proteins, inflammatory and immune-related signaling pathways (STAT3 and Nod pathways), and free fatty acid receptor 2 (FFAR2) inhibited the “inflammatory transformation” of colon cancer.